LSI

We have a stellar presenter lineup taking shape for LSI Asia ‘25. Today we’re introducing the first wave of global innovators selected to present in Singapore June 10-13. Here's a sneak peek at the global innovators confirmed to join us in Singapore: ? Dr Lynne Lim — Nousq Pte Ltd ? Alex Jiao — Scout ? Bora Chang, MD — KēlaHealth ? Jenny Hoffmann, PhD — Biorithm ? Shieak Tzeng — Wellumio ? James Lancaster — Solenic Medical Inc. ? Caitlin Morse — BrainSpace ? Malcolm Hebblewhite — Atmo Biosciences ? Lloyd Mencinger — AQUA Medical Want to join us at LSI Asia ‘25? Registration, applications for presenters, sponsorship opportunities, and our special hotel block rates are open. Secure your spot today on our website, or get in touch with our team to learn more.

The momentum continues to build for LSI Asia '25 as we introduce the first wave of global investors and strategics confirmed to join us in Singapore June 10-13. Here's a sneak peek at the global investors & strategics confirmed to join us in Singapore: ? Andrew Pieprzyk — Hologic, Inc. ? Chris Eso — Medtronic ? Dan Lippis — Edwards Lifesciences ? C David Adair MD, MBA, FACOG, FASH, C-EFM — Solas BioVentures ? William Dai — ShangBay Capital ? Dennis McWilliams — SANTé Ventures ? Michael Wang — Sunmed Capital ? Amir Soltanianzadeh — Solardis Health Ventures ? Steven M. Gottlieb, M.D. — The Gottlieb Family Office Want to join us at LSI Asia ‘25? Registration, applications for presenters, sponsorship opportunities, and our special hotel block rates are open. Secure your spot today on our website, or get in touch with our team to learn more.

Prescriby (LSI USA '25 Innovator) is an evidence-informed solution designed to enhance the safe prescribing of addictive medications. By addressing a critical gap in healthcare, Prescriby empowers providers to prevent addiction while streamlining workflows and saving valuable time. Best practice guidelines recommend that patients prescribed addictive medications receive education, close monitoring, and a tailored treatment plan to mitigate the risk of addiction. Yet, many healthcare professionals lack the time and tools to consistently meet these standards. Prescriby bridges this gap with its innovative platform. Prescriby has achieved many major milestones recently including: ? The company is running pilot projects on opioid and benzodiazepine tapering in Canada and Iceland, with plans underway to establish a pilot in the U.S. ? In Q2 2024, Prescriby secured a €2 million pre-seed round led by Crowberry Capital. This funding focuses on scaling operations in Canada and building momentum in the U.S. market as a clinical decision support tool. ? Beyond the current pilots, two additional projects are slated for Q1 2025, including a 540-patient clinical trial in Denmark. ? In Q3 2024, Prescriby was officially included in the Icelandic Directorate of Health's (Emb?tti Landl?knis) clinical guidelines for the safe prescribing of addictive medications. We’re excited to announce that Kjartan Thorsson has been selected to present Prescriby at LSI USA ‘25 March 17-21, 2025. Join us in Dana Point to meet with Kjartan and learn more about Prescriby.

What is the role of the CEO versus the board member, chair, or executive chair when making a first-time pitch to an investor, and how is that dynamic perceived? In this clip, the panel outlines the roles of the CEO and board members. They emphasized the importance of the CEO leading their investor pitches to showcase their ability to tell the company’s story and understanding of the business. When board members become too involved in the pitch it can signal a lack of confidence in the CEO’s abilities, potentially undermining their position. To hear more from this incredible group of panelists tune into the full LSI Europe ‘24 panel "Light at the End of the Tunnel in Medtech Financing”, on our website and YouTube channel featuring: ? Nick Pachuda (Moderator) — Precision Life Science Partners ? Martin Omid A. — Anthro Ventures ? Anita Watkins — Rex Health Ventures ? Sean Morris — Cultivation Capital ? Eman Namati — SpectraWAVE, Inc. - Want to attend our next event? LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

With today’s more stringent investor requirements in mind, it’s worth taking a look at a few of the stand-out Medtech investment deals completed thus far in 2024 to help identify common threads attracting investor interest. ??????????’?? ????????????, ??????????????????, ?????? ???????????????????????? ???????? ??????????-?????????? ?????????????? Of the early-stage Medtech rounds completed in the first half of the year, UK-based Amber Therapeutics’ huge $100 million Series A haul, which closed in June, tops the list. The company garnered one of the largest Series A rounds ever for a European Medtech company. Although the deal seems massive for a little-known company founded only three years ago, it should not be surprising given Amber’s focus on neuromodulation (one of the hottest growth areas) and women’s health (one of the most underserved), as well as its quick, cash-sparing path to the clinic (the company was founded in 2021, began its first human study in late 2022, and by early 2024 had preliminary results confirming the safety and feasibility of its technology). The Series A raise was financed by a syndicate of US and UK investors led by…. Continue reading this article and explore the full first edition of The Lens for free on our site. Subscribe today to receive the upcoming December issue and all 12 editions in 2025: https://lnkd.in/dZEXphUB

"LSI events are truly transformative for a young Medtech founder. The intimate, selective environment fosters organic connections, where every casual encounter, lunch break, and passing comment turns into pages of valuable notes. Set against a stunning backdrop, under the gentle sun, and within medieval monasteries, there’s no way I can call it a 'conference.' Every moment felt inspiring and productive, and I’m already looking forward to coming back." - Jeyla Sadikova, Co-Founder & CSO of illumicell AI Watch Jeyla and Michel Bielecki MD MPH’s LSI Europe ‘24 presentation to learn more about illumicell AI - available on our website and YouTube channel. - Want to join us in 2025? Our 2025 event schedule is now set with three events across the globe: ? LSI USA '25: March 17th – 21st (Dana Point, CA) ? LSI Asia '25: June 10th – 13th (Singapore) ? LSI Europe '25: September 7th – 11th (London) Visit our website or connect with our team to secure your spot at the best rate for any of our 2025 events.

Recode Ventures (LSI USA ‘25 Investor) is a specialized venture capital firm focused on investing in healthcare AI companies. Established in 2022, with offices in San Francisco and London, Recode partners with visionary founders who believe in the transformative potential of artificial intelligence and emerging technologies to revolutionize healthcare, tackling diseases that affect billions worldwide. Recode invests primarily in Seed and Series A companies, providing not just capital but also a robust support network. The team comprises seasoned investors and operators with extensive experience in research, drug development, product development, healthcare commercialization, market access, regulation, policy, and technology. Recode’s comprehensive approach is why it has become the chosen home for some of the most promising founders who are on a journey to reshape the future through the convergence of healthcare and technology. Recode Ventures' portfolio spans the United States and Europe and includes companies like: ? Proprio (LSI Alumni - Gabriel Jones) ? LabGenius (James Field) ? Sensible Biotechnologies (Miroslav Gasparek) ? Nanograb (YC S23) (Debesh Mandal) ? among others We’re excited to welcome Vishal Gulati, MD, Founder & Managing Partner, and Armen Vidian, Founder & Managing Partner of Recode Ventures to LSI USA ‘25 this March 17-21 in Dana Point, California. Want to see what other investors are joining us at LSI USA ‘25? Head over to our website to see a preview.

“It’s difficult to raise money, we all know that. But companies actually raise tens of millions and hundreds of millions today, thanks to the community that was built over the last 20 years.” - Antoine Papiernik, Chairman & Managing Partner, Sofinnova Partners This fireside chat with Dr. Josh Makower and Antoine Papiernik explored the key drivers of success in Medtech, emphasizing the importance of perseverance, collaboration, and investing in the right people. They highlighted the growth of the Medtech community and its unique spirit of cooperation, encouraging entrepreneurs and investors to focus on building transformative companies that address critical patient needs. Through personal stories and actionable insights, the two left us feeling inspired. The full “Fireside Chat with Josh Makower and Antoine Papiernik” is available on our website and YouTube channel. - Want to attend our next event? LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

"I urge people to look for simple use cases that are undeniably required by the healthcare system. Build meaningful scale with these first, and that buys you the right to build in the really interesting innovation later." - Imran Hamid, MD, Investment Director, LifeArc Ventures At LSI Europe ‘24, our panel "AI Infrastructure and the Future of Imaging,” explored how AI is being used to enhance disease characterization, streamline clinical workflows, and personalize treatments. The discussion highlighted key investment opportunities in the space, along with the challenges AI companies face, such as healthcare system adoption, reimbursement hurdles, and infrastructure gaps. The panelists also shared their thoughts on the future of AI in healthcare, emphasizing the importance of finding scalable use cases and the role of precision medicine in driving AI innovation. The full panel, "AI Infrastructure and the Future of Imaging,” is available on our website and YouTube channel featuring: ? Natasha Allen (Moderator) — Foley & Lardner LLP ? Sahirzeeshan (Sahir) Ali — Modi Ventures ? Imran Hamid, MD — LifeArc Ventures ? Soyoung Park — 1004 Venture Partners ? Vishal Gulati — Recode Ventures - Want to attend our next event? LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

The 2025 event calendar is set — Three events, three countries, and a world of possibilities. Join us in three iconic cities across three countries for a year filled with innovation and opportunity: LSI USA '25 (Dana Point) March 17th - 21st, 2025 At the Waldorf Astoria Monarch Beach Resort LSI Asia '25 (Singapore) June 10th - 13th, 2025 At The Ritz-Carlton? Millenia Singapore LSI Europe '25 (London) September 7th - 11th, 2025 At the JW Marriott Grosvenor House London If you plan on joining us next year, now is the perfect time to lock in our end-of-year rates for events and hotels. You can register today on our website or reach out to our team today. We look forward to seeing you in 2025!